These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34902455)

  • 21. Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial.
    Zaman A; de Winter RJ; Kogame N; Chang CC; Modolo R; Spitzer E; Tonino P; Hofma S; Zurakowski A; Smits PC; Prokopczuk J; Moreno R; Choudhury A; Petrov I; Cequier A; Kukreja N; Hoye A; Iniguez A; Ungi I; Serra A; Gil RJ; Walsh S; Tonev G; Mathur A; Merkely B; Colombo A; Ijsselmuiden S; Soliman O; Kaul U; Onuma Y; Serruys PW;
    Lancet; 2019 Mar; 393(10175):987-997. PubMed ID: 30827782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial.
    Zbinden R; Piccolo R; Heg D; Roffi M; Kurz DJ; Muller O; Vuilliomenet A; Cook S; Weilenmann D; Kaiser C; Jamshidi P; Franzone A; Eberli F; Jüni P; Windecker S; Pilgrim T
    J Am Heart Assoc; 2016 Mar; 5(3):e003255. PubMed ID: 26979080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial experience with the novel BioMime 60 mm-long sirolimus-eluting tapered stent system in long coronary lesions.
    Valero E; Consuegra-Sánchez L; Miñana G; García-Blas S; Rodríguez JC; Moyano P; Sanchis J; Núñez J
    EuroIntervention; 2018 Jan; 13(13):1591-1594. PubMed ID: 28870879
    [No Abstract]   [Full Text] [Related]  

  • 24. Uncommon but imperative cause of repeated acute stent thrombosis: Kounis syndrome type III.
    Miura S; Yamashita T; Murata M; Kounis NG
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33649028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ST-segment elevation versus non-ST-segment elevation myocardial infarction in current smokers after newer-generation drug-eluting stent implantation.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Medicine (Baltimore); 2021 Dec; 100(49):e28214. PubMed ID: 34889307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary bifurcations treated with thin-strut drug-eluting stents: a prespecified analysis of the randomized BIO-RESORT trial.
    Buiten RA; Warta S; Ploumen EH; Doggen CJM; van der Heijden LC; Hartmann M; Danse PW; Schotborgh CE; Scholte M; Linssen GCM; Zocca P; von Birgelen C
    Coron Artery Dis; 2021 Jan; 32(1):51-57. PubMed ID: 33278175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction.
    Colleran R; Kufner S; Harada Y; Giacoppo D; Cassese S; Repp J; Wiebe J; Lohaus R; Lahmann A; Schneider S; Ibrahim T; Laugwitz KL; Kastrati A; Byrne RA;
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):367-374. PubMed ID: 27377301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study.
    Naber CK; Urban P; Ong PJ; Valdes-Chavarri M; Abizaid AA; Pocock SJ; Fabbiocchi F; Dubois C; Copt S; Greene S; Morice MC;
    Eur Heart J; 2017 Apr; 38(13):961-969. PubMed ID: 27190095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial.
    Crimi G; Leonardi S; Costa F; Adamo M; Ariotti S; Valgimigli M
    Int J Cardiol; 2016 Jun; 212():110-7. PubMed ID: 27038714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of drug-eluting stents on 1-year risk of new-onset atrial fibrillation in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Yu FC; Chang YH; Chen IM; Liu HY; Lin CF; Chien LN
    Medicine (Baltimore); 2020 Aug; 99(34):e21885. PubMed ID: 32846847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.
    Sabaté M; Windecker S; Iñiguez A; Okkels-Jensen L; Cequier A; Brugaletta S; Hofma SH; Räber L; Christiansen EH; Suttorp M; Pilgrim T; Anne van Es G; Sotomi Y; García-García HM; Onuma Y; Serruys PW
    Eur Heart J; 2016 Jan; 37(3):229-40. PubMed ID: 26405232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abluminal biodegradable polymer biolimus-eluting versus durable polymer everolimus-eluting stent in patients with diabetes mellitus: 5 years follow-up from the COMPARE II trial.
    Paradies V; Vlachojannis GJ; Royaards KJ; Wassing J; van der Ent M; Smits PC
    Int J Cardiol; 2019 Sep; 290():40-44. PubMed ID: 31101545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents.
    Lee DH; Park TK; Song YB; Chun WJ; Choi RK; Jeong JO; Im ES; Kim SW; Lee JM; Yang JH; Hahn JY; Choi SH; Choi JH; Lee SH; Gwon HC
    PLoS One; 2017; 12(8):e0183079. PubMed ID: 28797113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute ST Elevation Myocardial Infarction Due to Allergic Reaction, Kounis Syndrome.
    Rajha E; Didi A; Dakik H; Mufarrij A
    Am J Emerg Med; 2020 Feb; 38(2):409.e5-409.e7. PubMed ID: 31785976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes.
    Zhang H; Wang X; Deng W; Wang S; Ge J; Toft E
    Medicine (Baltimore); 2016 Sep; 95(38):e4820. PubMed ID: 27661023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial.
    von Birgelen C; Asano T; Amoroso G; Aminian A; Brugaletta S; Vrolix M; Hernandez-Antolín R; van de Harst P; Iñiguez A; Janssens L; Smits PC; Wykrzykowska JJ; Ribeiro VG; Pereira H; da Silva PC; Piek JJ; Onuma Y; Serruys PW; Sabaté M
    EuroIntervention; 2018 Apr; 13(17):2026-2035. PubMed ID: 28923787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.
    de Winter RJ; Katagiri Y; Asano T; Milewski KP; Lurz P; Buszman P; Jessurun GAJ; Koch KT; Troquay RPT; Hamer BJB; Ophuis TO; Wöhrle J; Wyderka R; Cayla G; Hofma SH; Levesque S; Żurakowski A; Fischer D; Kośmider M; Goube P; Arkenbout EK; Noutsias M; Ferrari MW; Onuma Y; Wijns W; Serruys PW
    Lancet; 2018 Feb; 391(10119):431-440. PubMed ID: 29203070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved clinical outcome with biodegradable polymer drug-eluting stents compared to durable polymer drug-eluting stents for primary percutaneous coronary intervention.
    Andriyati R; Firman D; Kurniawati Y; Alkatiri AA; Pranata R; Muliawan HS; Rossimarina V; Soerianata S
    Postgrad Med J; 2021 Oct; 97(1152):638-643. PubMed ID: 32796116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kounis syndrome is the likely culprit in devastating stent thrombosis.
    Kounis NG; Almpanis GC; Tsigkas GG; Mazarakis A
    J Invasive Cardiol; 2011 Mar; 23(3):3 p preceding 88. PubMed ID: 21473170
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.
    Palmerini T; Benedetto U; Biondi-Zoccai G; Della Riva D; Bacchi-Reggiani L; Smits PC; Vlachojannis GJ; Jensen LO; Christiansen EH; Berencsi K; Valgimigli M; Orlandi C; Petrou M; Rapezzi C; Stone GW
    J Am Coll Cardiol; 2015 Jun; 65(23):2496-507. PubMed ID: 26065988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.